ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting
April 12, 2021Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, presented updated long-term follow-up data on their TruUCAR-enabled ...
Pharma Sources Insight January 2025
